Assertio Logo.jpg
Assertio Announces the Appointment of Brendan P. O’Grady as New CEO
May 29, 2024 07:00 ET | Assertio Holdings, Inc.
Assertio appoints Brendan P. O'Grady as CEO
Assertio Logo.jpg
Assertio to Participate in Benchmark Healthcare Conference on May 21-22
May 17, 2024 09:15 ET | Assertio Holdings, Inc.
LAKE FOREST, Ill., May 17, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering...
Assertio Logo.jpg
Assertio to Participate in AGP Healthcare Conference on May 21
May 16, 2024 09:16 ET | Assertio Holdings, Inc.
LAKE FOREST, Ill., May 16, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering...
Assertio Logo.jpg
Assertio Reports First Quarter 2024 Financial Results
May 06, 2024 16:01 ET | Assertio Holdings, Inc.
First Quarter Net Product Sales of $31.9 Million Rolvedon Growth Continues, with $14.5 million in Net Product Sales $7.5 Million in Cash Flow from Operations Increases Cash to...
Assertio Logo.jpg
Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024
April 25, 2024 08:00 ET | Assertio Holdings, Inc.
LAKE FOREST, Ill., April 25, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Logo.jpg
Sig Kirk Joins Assertio Board of Directors
April 03, 2024 08:00 ET | Assertio Holdings, Inc.
LAKE FOREST, Ill., April 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Logo.jpg
Assertio to Present at LD Micro Invitational Conference in New York City
April 01, 2024 09:00 ET | Assertio Holdings, Inc.
LAKE FOREST, Ill., April 01, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
BES_Mark.jpg
ASSERTIO ALERT: Bragar Eagel & Squire, P.C. is Investigating Assertio Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
March 27, 2024 21:00 ET | Bragar Eagel & Squire
NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Assertio Holdings, Inc....
Assertio Logo.jpg
Assertio Reports Fourth Quarter and Full Year 2023 Financial Results
March 11, 2024 16:01 ET | Assertio Holdings, Inc.
Fourth Quarter Net Product Sales $32.5 Million, Cash Flow from Operations of $5.7 Million 2024 Full Year Outlook for Net Product Sales of $110 to $125 Million,...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for ASRT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
March 05, 2024 11:15 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, March 05, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...